Profil
Kevin Chen is associated with the firm Hyasynth Biologicals, Inc. as the Chief Executive Officer since 2014.
He is the founder of the company which was also founded in 2014.
Aktive Positionen von Kevin Chen
| Unternehmen | Position | Beginn |
|---|---|---|
Hyasynth Biologicals, Inc.
 Hyasynth Biologicals, Inc. BiotechnologyHealth Technology Hyasynth Biologicals, Inc. manufactures natural cannabinoid compounds. It offers researchers, doctors, and patients with options in treating multiple sclerosis, epilepsy (dravet syndromes), Alzheimer’s diseases, chronic pains, inflammations, and muscular dystrophy diseases. The company was founded by Alex Campbell, Kevin Chen, Shoham Mookerjee, Sarah Choukah and Zach Wiltshire and is headquartered in Montreal, Canada. | Vorstandsvorsitzender | 01.01.2014 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Hyasynth Biologicals, Inc.
Hyasynth Biologicals, Inc. BiotechnologyHealth Technology Hyasynth Biologicals, Inc. manufactures natural cannabinoid compounds. It offers researchers, doctors, and patients with options in treating multiple sclerosis, epilepsy (dravet syndromes), Alzheimer’s diseases, chronic pains, inflammations, and muscular dystrophy diseases. The company was founded by Alex Campbell, Kevin Chen, Shoham Mookerjee, Sarah Choukah and Zach Wiltshire and is headquartered in Montreal, Canada. | Health Technology |
